Kestra Private Wealth Services LLC Grows Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Kestra Private Wealth Services LLC lifted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 105.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 29,106 shares of the company’s stock after purchasing an additional 14,912 shares during the period. Kestra Private Wealth Services LLC’s holdings in Hims & Hers Health were worth $704,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Crewe Advisors LLC purchased a new position in Hims & Hers Health in the fourth quarter valued at about $28,000. Raleigh Capital Management Inc. grew its holdings in Hims & Hers Health by 1,100.0% in the fourth quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company’s stock valued at $29,000 after purchasing an additional 1,100 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Hims & Hers Health by 2,173.7% in the fourth quarter. GAMMA Investing LLC now owns 2,251 shares of the company’s stock valued at $54,000 after buying an additional 2,152 shares in the last quarter. Quest Partners LLC raised its stake in shares of Hims & Hers Health by 22.6% during the 3rd quarter. Quest Partners LLC now owns 4,373 shares of the company’s stock worth $81,000 after buying an additional 807 shares during the last quarter. Finally, CWM LLC boosted its position in shares of Hims & Hers Health by 21.4% in the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares in the last quarter. Institutional investors and hedge funds own 63.52% of the company’s stock.

Wall Street Analysts Forecast Growth

HIMS has been the topic of several recent research reports. Morgan Stanley started coverage on shares of Hims & Hers Health in a report on Tuesday, December 17th. They issued an “overweight” rating and a $42.00 price target on the stock. Piper Sandler lifted their price objective on Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. BTIG Research began coverage on shares of Hims & Hers Health in a report on Tuesday, January 7th. They issued a “buy” rating and a $35.00 target price on the stock. Bank of America downgraded shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and lowered their price target for the stock from $32.00 to $18.00 in a report on Thursday, November 14th. Finally, Canaccord Genuity Group raised their target price on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $25.13.

Insider Buying and Selling

In other Hims & Hers Health news, CEO Andrew Dudum sold 33,513 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $33.38, for a total transaction of $1,118,663.94. Following the transaction, the chief executive officer now owns 33,502 shares in the company, valued at $1,118,296.76. The trade was a 50.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Soleil Boughton sold 2,343 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $29.90, for a total value of $70,055.70. Following the sale, the insider now owns 165,254 shares in the company, valued at approximately $4,941,094.60. The trade was a 1.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,111,554 shares of company stock valued at $33,865,763. Company insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Up 2.1 %

HIMS opened at $60.41 on Friday. Hims & Hers Health, Inc. has a 52-week low of $9.22 and a 52-week high of $64.84. The company has a 50 day moving average of $32.06 and a two-hundred day moving average of $24.26. The company has a market cap of $13.20 billion, a P/E ratio of 137.31 and a beta of 1.35.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.